Relation Between Bone Density and the Regulation of Mineral Metabolism in Renal Stone Formers
NCT ID: NCT00416052
Last Updated: 2011-05-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
90 participants
OBSERVATIONAL
2004-03-31
2006-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Workup in Patients Suffering From Kidney Stone Disease and Osteopenia
NCT04080973
Clinical Observation on Bone Metabolism Induced by Chronic Renal Insufficiency
NCT02147782
A Natural History Study of Bone and Mineral Disorders
NCT00024804
Relationship Between Homocysteine and BMD
NCT04821492
Association Between DXA Results and the Complications, Clinical Courses and Outcomes in Chronic Dialysis Patients
NCT02616627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
We hypothesize now that PTH and 1,25-vitamin D change differently when calcium stone formers with high, intermediate and low BMD are challenged by a low calcium diet.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* creatinine clearance \< 60 ml/min
* urinary tract infection
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Insel Gruppe AG, University Hospital Bern
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Nephrology and Hypertension, Inselspital, University Hospital Bern
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Felix J Frey, MD
Role: STUDY_DIRECTOR
University of Bern
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. Nephrology & Hypertension, Univ. Hospital Bern
Bern, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BE001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.